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Glioma in dogs: interest of spontaneous models for the genetics of
human gliomas
Maud Rimbault1, Clotilde De Brito1, Aline Primot1, Ronan Ulvé1, Mélanie
Rault1, Nadine Botherel1, Catherine Escriou2, Jérôme Abadie3, Laetitia
Lagoutte1, Delphine Dullin2, Dominique Fanuel3, Marie-Anne Colle3,
Patrick Devauchelle4, Jean-Laurent Thibaud4, Stéphane Blot5, Audrey
Rousseau6, Jean Mosser1, Philippe Menei7, Benoît Hédan1
and Catherine André1
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comportement), VetAgro-Sup, Marcy l’Etoile, France; 3Unité AMaROC,
Oniris, Atlanpole La Chantrerie, Nantes, France; 4MICEN VET, Europarc,
Créteil, France; 5UPR de Neurobiologie, Ecole Nationale Vétérinaire
d’Alfort, Maisons Alfort, France; 6Département de Pathologie Cellulaire et
Tissulaire, CHU d’Angers, Angers, France; 7Département de
Neurochirurgie, INSERM U1066, CHU d’Angers, Angers, France
Correspondence: Maud Rimbault
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Human glioma are brain cancers with a dramatic 5 year survival time
of 5% even applying the unique reference treatment based on radio-
and chemotherapy. Interestingly, among the many dog breeds prone
to spontaneously develop cancers, brachycephalic breeds (Boxers,
Bulldogs, Boston terriers…) are particularly affected by glial tumors.
Dogs share the same environment as humans and have also anatom-
ical and physiological similarities, thus constituting a relevant model
for the genetics and therapies of brain tumors.
Thanks to the national Cani-DNA biobank and its veterinary network
(the 4 Veterinary Schools, Antagene, private practices and cancer
centers) managed at CNRS Rennes (France), samples for 50 glioma af-
fected and >100 control dogs, as well as 1400 brachycephalic dogs
have been collected and DNA extracted and stored.
With the goal to compare dog and human gliomas in mind, we per-
formed a retrospective study of 100 canine glioma cases, allowing a
clinical, epidemiological and histological characterization of these© The Author(s). 2018 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zecanine tumors. The predominant localization of glioma to the frontal
lobe, predisposed breeds (mainly brachycephalic dogs from the
European Mastiff line) and mean age of onset were revealed by the
analysis of 20 cases with imaging and 15 cases with histology. We
showed that dog gliomas present surprising anatomic and clinical
homologies, with comparable histopathological subtypes as in hu-
man gliomas.
These results led us to analyze 2 cases for which brain tissue had
been collected. We identified a BRAF-MBP gene fusion in one case
using RNAseq and we are currently checking for recurrence in the
collected samples, as well as for the presence of this translocation in
human glioma cases. Using affected cases and controls of the same
breeds, we plan to pursue the identification of somatic alterations by
transcriptome analyzes (RNAseq) and exome sequencing (WES) and
to carry out genetic linkage and/or genetic association studies
(GWAS) to identify genomic regions involved in predisposition. We
will also search if and how the artificial selection that led to specific
morphological characteristics, such as the shape of the dog’s skull
(brachycephaly), would have also led to glioma predisposition.
Keywords: Canine, Genomics and Variation, Inherited Disease
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Use of cross-country data for estimation of heritability of longevity
and heart-related deaths in Doberman Pinscher
Joanna J. Ilska1, Paolo Gottardo2, John Hickey1, Dylan Clements3
1The Roslin Institute and Royal (Dick) School of Veterinary Studies,
Edinburgh, Scotland; 2Italian Brown Swiss Breeding Association, Italy;
3Royal (Dick) School of Veterinary Studies and The Roslin Institute,
Edinburgh, Scotland
Correspondence: Joanna J. Ilska
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Genetic improvement with the use of Estimated Breeding Values
(EBV) is a method which, after decades of successful and validated
use in livestock species, slowly gains recognition in the world of dogs
breeding. However, accurate EBV prediction for complex traits re-
quires large datasets of phenotyped and related animals. While gen-
eration of such datasets is possible in the most popular dog breeds,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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tional database is not likely. Further, collection of the data pertaining
to diseases through national Kennel Clubs is usually limited to very
few already established grading systems for specific diseases, such as
British Veterinary Association’s scheme for Hip and Elbow Dysplasia.
Thus, databases created by independent breed societies combining
records across countries and on breed-specific issues, could become
sources of data for the genetic analyses and EBV predictions in nu-
merically small breeds. We present a preliminary analysis of the herit-
ability of longevity and heart-related deaths (HEART) in Doberman
Pinscher, based on data collated by The Doberman Welfare Commu-
nity (DWC) – an independent group of breed enthusiasts. The data
included over 350,000 dogs over 37 genera tions, born between
1890 and 2017, and from 18 regions. Phenotypic records on longev-
ity and cause of death were recorded for 10,549 and 5,844 dogs re-
spectively. Neither longevity nor causes of death are currently
recorded by national kennel clubs, thus highlighting the role of the
DWC in collecting this type of data. Among the causes of death,
HEART were most common (48%), and more frequent in males than fe-
males (55% males, 45% females). The average longevity (LONG – num-
ber of months between birth and death) was 89 months (7 years) for
males and 100 months (8 years) for females.
A number of mixed linear models were fitted to identify significant
environmental factors affecting LONG and HEART, and to estimate
heritability of the traits. LONG was Box-Cox transformed to improve
normality of the data, and binomial models were fitted for the herit-
ability estimation of the underlying liability for the HEART. Factors
identified as significant for HEART were sex, region, season of birth, and
year of death. LONG was affected by year and season of birth, as well
as year of death. Heritability of the HEART and LONG was 0.29 ( 0.02)
and 0.11 ( 0.02) respectively. To the best of our knowledge, these are
the first published estimates of heritability of longevity and heart-
related deaths in Dobermans using owner-collated data. A significant
genetic variance detected for both traits indicates that selection could
bring improvement in these traits, which is particularly important for
HEART – heart conditions are believed to affect as many as 20% of
Dobermans, and the symptoms of the disease often appear after a dog
has already been used for breeding. Further, significant estimates ob-
tained in the presented analyses indicate validity of the data, thus
opening a new window of opportunity for genetic analyses of complex
traits in numerically small breeds through the recruitment and collation
of data by breed enthusiasts.
Keywords: Canine, Genomics and Variation, Inherited Disease
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Canine breed specific cancers as natural models for rare and/or
aggressive human cancer types: examples of sarcomas,
melanomas, lymphomas and gliomas
Benoit Hédan1, Mélanie Rault1, Ronan Ulvé1,2, Aline Primot1, Edouard
Cadieu1, Clotilde de Brito1, Nadine Botherel1, Maud Rimbault1, Jérôme
Abadie3, Anne-Sophie Guillory1, Anais Prouteau1, Amaury Vaysse1, Patrick
Devauchelle4, Annabelle Garand1, Celine Le Beguec1, Laetitia Lagoutte1,
Valentin Wucher1, David Gilot1, Thomas Derrien1, Christophe Hitte1,
Catherine André1
1Institut Génétique et Développement de Rennes, CNRS-UMR6290,
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Agroalimentaire et de l’Alimentation Nantes Atlantique, 44307, Nantes,
France; 4Centre de Cancérologie Vétérinaire, MICEN Vet 58 rue Auguste
Perret, 94000, Creteil, France
Correspondence: Catherine André
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Through the French Cani-DNA biobank, developed in the team since
2005, we have collected over 3000 samples (blood and paired tumour/
normal tissues) form many dogs affected by breed specific cancers, as
well as controls of the same breeds, for which there are specific issues
in the human corresponding cancers. Indeed, naturally occurring ca-
nine cancers are recently receiving attention in comparative oncologybecause of their high similarity to human cancers both in their clinical
and histological presentations as well as in their response to
treatments.
We have constituted large collections of cases and controls as well
as large family pedigrees and through genome wide association
studies (GWAS) and genetic linkage approaches, we have identified
predisposition loci for Histiocytic Sarcoma (HS) and oral melanomas.
In parallel, through the search of somatic genetic alterations in the
tumour (whole exome sequence -WES-; capture/sequencing and
RNAseq techniques), we have identified relevant genetic alterations
in canine lymphomas, sarcomas, melanomas and gliomas. Either we
found new genes implicated in dogs and we could identify the same
genes in the corresponding human cancers, or we found already
known genes, especially oncogenes with the same hotspots than in
humans, as well as gene fusions with the same partners and the
same over-expression mechanism than in humans, for lymphoma,
sarcoma and glioma (Ulvé, Rault et al., 2017). We have identified such
genes and their pathogenic somatic alterations for HS (TP53 and a
MAPK oncogene), melanomas (over 50 genes, including PTEN, NRAS),
lymphomas (26 genes, including cyclins) and gliomas (a BRAF- MBP
fusion). For oral melanomas, we also have identified specific Copy
Number alterations (CNA) that we showed to be significantly linked
to survival.
Finally, we developed cell lines for these canine cancers (8 for HS, 10
for oral and uveal melanomas, 2 for gliomas and 1 for lymphoma),
and were able to demonstrate the effect on proliferation, of drugs
targeting genes coding for MAPK pathway oncogenes and cyclin
genes, for HS and lymphomas respectively. We thus showed that ca-
nine cancers might be highly useful for clinical trials, as in vitro and
in vivo models to screen drugs in dog/human homologous cancers,
prior to test them in humans, in the frame of the treatment of the
dogs and with the owner partnership and consent. Finally, to also
benefit breeders, we also developed a genetic risk test for Histiocytic
Sarcoma, made of 9 markers predictive of a “protective” or “at risk”
haplotype and status, available for breeders to help their selection
against HS in the Bernese Mountain Dog breed.
To conclude, these genetic findings bring a better understanding of
the genetics and potential treatments for dog but also for human
medicine. More widely, these results show the interest of the dog
model to decipher the genetic bases and plan clinical trials in dogs
for rare and/ or aggressive-refractory human cancers.
O4
Association of primary open angle glaucoma ADAMTS17
mutations with height in two domestic dog breeds
Emily Jeanes1, James Oliver2, Sally L. Ricketts2, David Gould3,
Cathryn Mellersh2
1Centre for Small Animal Studies, Animal Health Trust, Lanwades Park,
Kentford, Newmarket, CB8 7UU, UK; 2Canine Genetics Research Group,
Kennel Club Genetics Centre, Animal Health Trust, Lanwades Park,
Kentford, Newmarket, CB8 7UU, UK; 3Davies Veterinary Specialists, Manor
Farm Business Park, Higham Gobion, Hitchin, SG5 3HR, UK
Correspondence: Sally L. Ricketts
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There are currently five known ADAMTS17 mutations in the dog that
are associated with the development of either primary open angle
glaucoma or primary lens luxation. Interestingly, these mutations
have been identified in breeds of generally short stature including
terriers and Basset breeds. In humans, mutations in the ADAMTS17
gene are associated with Weill-Marchesani syndrome – a disorder
whose clinical characteristics include ocular manifestations such as
microspherophakia, myopia, glaucoma, and cataract, in addition to
brachydactyly and short stature. This led us to hypothesise that these
mutations may also be associated with height in these breeds. To
test this, we conducted an association analysis between breed-
specific ADAMTS17 mutations and height in two of these breeds –
the Petit Basset Griffon Vendeen and Shar Pei. Two hundred and
twenty-seven Petit Basset Griffon Vendeen and 65 Shar Pei were ge-
notyped for their breed-specific ADAMTS17 mutations. The height of
Canine Genetics and Epidemiology 2018, 5(Suppl 2):7 Page 3 of 8each dog was measured at the withers. We used linear per allele re-
gression to assess the association between ADAMTS17 mutations
and height as a continuous variable, and linear regression and log-
likelihood ratio tests to assess the shape of the association by com-
paring a general model with a linear per allele model. The mean
heights of affected (n=21), carrier (n=84) and clear (n=122) Petit Bas-
set Griffon Vendeen were 33.41 cm, 34.78 cm and 34.93 cm, respect-
ively. The mean heights of affected (n=9), carrier (n=30) and clear
(n=26) Shar Pei were 43.32 cm, 47.93 cm and 48.38 cm, respectively.
Each breed-specific ADAMTS17 mutation showed a strong associ-
ation with height in both breeds: Petit Basset Griffon Vendeen (P=7.9
x 10-3); Shar Pei (P=6.9 x 10-5). The shape of the associations ap-
peared similar between the two breeds. In humans, ADAMTS17 af-
fects skeletal development by modulating the extracellular matrix. A
similar mechanism may be present in the dog. We speculate that se-
lection for short stature might have inadvertently increased
ADAMTS17 mutant allele frequencies and thus increased prevalence
of primary open angle glaucoma in these breeds.
Keywords: Canine, Morphology
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Detection and characterisation of a genetic association with
Norwich Terrier Upper Airway Syndrome
Thomas Marchant1, Elisabeth Dietschi2, Ronan Harrington1, Michaela
Drögemüller2, Ulrich Rytz3, Elaine A. Ostrander4, Tosso Leeb2
& Jeffrey J. Schoenebeck1
1The Royal (Dick) School for Veterinary Studies and Roslin Institute, The
University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK; 2Institute
of Genetics, Vetsuisse Faculty, University of Bern, 3001, Bern, Switzerland;
3Department of Clinical Veterinary Medicine, Division of Small Animal
Surgery, Vetsuisse Faculty, University of Bern, 3001, Bern, Switzerland;
4Cancer Genetics Branch, National Human Genome Research Institute,
Bethesda, MD, USA
Correspondence: Thomas Marchant
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In domestic dogs, the “flat-faced” brachycephalic head shape is a
risk factor for developing the respiratory defect, Brachycephalic
Obstructive Airway Syndrome (BOAS). As the popularity of breeds
such as the French bulldog continues to increase in the UK, so
too are the expected incidences of BOAS. For this reason, we be-
came interested in the Norwich terrier, a non- brachycephalic
breed which presents with Upper Airway Syndrome (UAS), a con-
dition highly reminiscent of BOAS. Here, we have studied this sin-
gle breed to identify genetic association(s) with UAS. Pathological
assessments and grading from laryngoscopic examinations held
at the Vetsuisse Faculty of the University of Bern, were used as
phenotypes in conjunction with microarray genotypes to perform
GWAS. In total, 233 Norwich terriers were examined. We identi-
fied the same QTL on canine chromosome (CFA) 13 to be associ-
ated with the abnormal positioning of laryngeal cartilage and
everted saccules in the dogs most severely affected by UAS. We
phased genotypes at the CFA13 QTL to conduct haplotype map-
ping, which led us to define a 413 kb critical interval which en-
compasses a single positional candidate gene. The derived
haplotype within this interval is overrepresented: it is found to
be homozygous in 61 of 81 (74%) severely affected cases. In con-
trast, this homozygous haplotype was identified among 7 of 86
(8.1%) mild/unaffected controls. We have resequenced four dogs
representing phenotypic extremes to sixteen-fold depth to iden-
tify putatively causal variants. We will provide an update to this
ongoing project, which is expected to guide Norwich terrier
breeding and inspire additional exploration of the CFA13 locus to
improve animal welfare.
Keywords: Canine, Inherited Disease, MorphologyO6
Identification and characterisation of a mutation associated with
cerebellar ataxia in the Norwegian Buhund dog breed
Chris Jenkins1, Lajos Kalmar3, Lorenzo Mari2, Ellen Schofield1,
Cathryn Mellersh1, Luisa De Risio2*, Sally Ricketts1*
1Kennel Club Genetics Centre, Animal Health Trust, Newmarket, UK;
2Neurology/ Neurosurgery Service, Centre for Small Animal Studies,
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Medicine, University of Cambridge, Cambridge, UK
Correspondence: Chris Jenkins
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Inherited ataxias are typically incurable and lack disease-modifying
treatments. Four Norwegian Buhunds were diagnosed with cerebellar
ataxia at the Animal Health Trust. Pedigree analysis was suggestive of
an autosomal recessive mode of inheritance, which is typical of inher-
ited canine ataxias. The causal variant for ataxia in these dogs was
hypothesised to be private to the breed. Whole genome sequence
(WGS) was obtained for two sibling cases, which were compared to
WGS from 405 dogs of other breeds. The WGS used included 44 which
were generated for the study of other diseases in our laboratory, and
361 additional WGS which are part of the Dog Biomedical Variant Data-
base Consortium. Filtering out benign variants left nine that were
present only in the cases and predicted to directly affect a protein cod-
ing sequence or alter a transcript. These were assessed in 14 related
and unrelated Buhunds, leaving one variant that fully segregated with
the disease. Its association with ataxia was confirmed by typing in an
extended set of 148 Buhunds containing two additional cases, and its
absence in 359 dogs of 122 other breeds. This research has resulted in
the development of a DNA test enabling breeders to avoid producing
affected dogs. Importantly, the causal mutation is within a gene not
previously reported to be associated with ataxia in any species. A com-
bination of approaches was used to characterise this gene in the dog,
as the current CanFam 3.1 annotation is incorrect. The gene is highly
conserved and, in humans and mice, encodes multiple transcripts with
alternative first exons. Expression of multiple transcripts in the canine
cerebellum was confirmed through RNA sequencing, and through RT-
PCR of samples from two Norwegian Buhund cases and five unaffected
dogs of other breeds. RT-qPCR analysis and in-silico protein modelling
have been used to further investigate the mutation’s effect on RNA ex-
pression and protein stability.
Keywords: Canine, Inherited Disease
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Ontogenic transcriptomic profiling identifies signalling pathways
driving pathogenesis in canine myxomatous mitral valve disease
Greg R. Markby1, Kim M. Summers1,2, Vicky E. MacRae1,
Brendan M. Corcoran1,3
1The Roslin Institute, Edinburgh, Scotland; 2Mater Research Institute,
Brisbane, Australia; 3The Royal (Dick) School of Veterinary Studies,
Edinburgh, Scotland
Correspondence: Brendan M. Corcoran
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Chronic degenerative diseases (CDGs) are a major welfare concern in
canine medicine with myxomatous mitral valve disease (MMVD) be-
ing an important example. For some breeds CDGs can have an inher-
ited basis, but often this is a polygenic trait and so understanding
the mechanisms that drive disease pathogenesis requires examining
molecular events in tissue. Specifically for CDGs this requires examin-
ation in both temporal and spatial terms changes in gene and pro-
tein expression. In this study we have examined the valvular gene
expression at different stages of disease (temporal), different loca-
tions (spatial) and in different cell culture models of MMVD.
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Transcriptomic profiling (Affymetrix canine 1.1ST microarray), with valid-
ation using RT-qPCR for selected genes, was performed on, whole valves
from normal and the 4 grades of MMVD (n=6),normal and diseased re-
gions of grade 2 valves (n=7), and cultured (all experiments n=3) normal
and diseased valve interstitial cells (VICs), normal cells treated with 5ng/
μL TGFβ1 and diseased cells treated with 10μM of the TGFβ pathway in-
hibitor SB431542. Microarray data were analysed using a range of bio-
informatics platforms (Affymetrix Console, IPA, Miru (Biolayout Express)).
Results
Significantly differentially expressed genes (DEG) were identified
comparing: 1) normal and the 4 grades of MMVD (1002 genes); 2)
diseased and normal tissue within the same valve (315 genes); 3)
normal and diseased VICs (1027 genes); 4) normal VICs and normal
VICs treated with TGF-β1 (302 genes); 5) diseased VICs and diseased
treated with VICs SB431542 (269 genes).
Grade-dependent up and down regulated gene clusters were identi-
fied, and microarray data were validated by RT-PCR for ACTA2,
TAGLN and 5HTR2B. Important GO-terms were found to be associ-
ated with myofibroblast differentiation and extracellular matrix
homeostasis. In all data sets altered DEGs implicated TGF-β1 as the
important up-stream regulator of disease pathogenesis, with minor
contributions from TNF and IFNG. 75 DEGs were shared in common
between grade 4 whole valve and the diseased sections of the dis-
sected valves. Cultured cell data, in addition to TGFβ1, predicted
genes involved in cell cycle and apoptosis as important up-stream
regulators.
Conclusions
This study shows how transcriptomic profiling of chronic degenera-
tive disease over an entire lifetime, in tandem with cell culture
models, can identify the signalling pathways important in disease
pathogenesis. TGFβ1 signalling has been identified as the fundamen-
tally important pathway in MMVD initiation and development, and
progression to eventual end-stage valve pathology.
The authors gratefully acknowledge funding from Dogs Trust
Keywords: Canine
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Genetic analyses of Lhasa Apso dogs with progressive retinal
atrophy identifies a LINE-1 insertion in the promoter region of a
retinal candidate gene
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Canine progressive retinal atrophy (PRA) is a degenerative retinal dis-
ease characterised by photoreceptor degeneration over time, increas-
ing in severity and ultimately leading to vision loss. PRA affects
multiple breeds and significantly impacts welfare. In the Lhasa Apso
(LA) dog, PRA manifests typically as a mid-late onset form. Utilisation
of whole-exome sequencing (WES) data previously generated in our
laboratory from three PRA-affected LA (cases) and three PRA-
unaffected LA (controls) did not reveal any obvious exonic or splice
site polymorphisms segregating with the disease, indicating a non–
coding mutation. This presented the opportunity for further investi-
gations using a genome-wide association study (GWAS) and whole-
genome sequencing (WGS) approach to identify the genetic cause of
PRA and develop a DNA test.
A GWAS was conducted by genotyping 44 LA dogs (17 cases, 27
controls) on the Illumina Canine HD 170K chip. Allelic association sta-
tistics were adjusted for multiple testing using the PLINK Max(T) per-
mutation procedure, and for population stratification and relatedness
using Efficient Mixed-Model Association eXpedited (EMMAX). After
stringent filtering and quality control, we tested 108,263 SNPs on 42
dogs, comprising 15 cases and 27 controls (call rate ≥97%; minor al-
lele frequency ≥95%; genotype calls ≥90%). Analysis revealed agenome-wide significant association on canine chromosome 33 (-log
praw = 2.2 x 10-16) which remained significant after correcting for
multiple testing (pgenome = 0.9 x 10-5) and population substructure
(p=raw1.6 x 10-17). A 1.3 megabase homozygous disease-associated
region was defined, harbouring two candidate genes previously asso-
ciated with human retinal degeneration.
WGS was undertaken on a single PRA affected LA, and manual inter-
rogation of the critical region in identified a long interspersed nu-
clear element-1 (LINE-1) insertion, situated within the predicted
promotor region of a retinal candidate gene. Due to the position of
the LINE-1 insertion, it was not detected in the original WES data of
the same case. The LINE-1 insertion was genotyped in 447 dogs
across 122 breeds, including 63 LA dogs, and is private to the LA.
Seventeen LA dogs (all clinically affected with PRA) were homozy-
gous for the LINE-1 insertions, eight were heterozygous and thirty-
eight were homozygous for the wildtype allele.
As a result of this study a DNA test for this form of PRA, termed
PRA4, has been developed at the Animal Health Trust. To date, 457
LA from 15 countries have been tested for PRA4 (354 UK dogs; car-
rier frequency 17%; allele frequency 0.9054). This study highlights
the power of utilising several genetic approaches to identify a PRA
mutation and develop a diagnostic test to help dog breeders make
informed breeding choices, minimising the risk of producing PRA-
affected LA dogs.
Keywords: Canine, Inherited Disease
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In humans, there are many forms of sensory neuropathies, associated
or not with a loss of sensitivity to pain and sometimes accompanied
by self-mutilation. Although to date 13 genes have already been im-
plicated in this disease, they do not explain the genetic causes of all
patients.
Canine Genetics and Epidemiology 2018, 5(Suppl 2):7 Page 5 of 8Similar neuropathies are diagnosed in dogs and several breeds are at risk
to develop certain forms. Neuropathy has been described in hunting
dogs, where the condition results in progressive mutilation of the distal
extremities of the paws (Paradis et al., 2005). Pedigree analysis led to con-
clude to a monogenic autosomal recessive mode of inheritance. Blood
samples from affected and unaffected hunting dogs from France and
from Canada were collected through the French Cani- DNA biobank
(dog-enetics.genouest.org). Genetic studies (GWAS and sequencing) led
to the identification of a locus on canine chromosome 4, and to a muta-
tion located 90kb upstream GDNF, a gene encoding a neurotrophic fac-
tor involved in the survival of dopaminergic neurons. This mutation
segregates as expected in 300 hunting dogs of known clinical status and
is not found in 900 dogs of 90 other non-predisposed breeds. Functional
experiments have shown that the mutation causes a decrease of GDNF
expression in the dorsal root ganglia and also a decrease in the affinity of
a regulatory complex for the DNA sequence to which it binds (Plassais
et al., 2016). This gene had not previously been involved in human forms
of sensory neuropathy and appears a good candidate. Through French
and Belgium reference centers, we collected 111 DNAs of patients af-
fected with different forms of sensory neuropathies and we sequenced
GDNF exons as well as two regions predicted as regulatory, orthologous
to the mutated regulatory region in the dog.
23 variants were identified and classified:
i. New variants (not listed in human databases).
ii. Rare variants (listed in databases with a minor allele frequency
inferior to 1%).
No new variants have been found in the coding parts of the gene,
however, 6 new variants have been identified in the UTRs and regu-
latory regions upstream GDNF and 17 rare variants were also
identified.
In conclusion, the dog model has allowed to identify a new gene for
canine and potentially human sensory neuropathies. New and rare
variants in this gene are being analyzed to tentatively identify their
potential role in human neuropathies.
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Retinitis pigmentosas (RP) are genetically heterogeneous, progressive
diseases characterised by retinal degeneration and causing loss of vi-
sion before middle age, and affecting in 1 in 2000 humans. The ca-
nine equivalent, progressive retinal atrophy (PRA) is untreatable and
affects multiple dog breeds, significantly impacting dog welfare.
A novel form of PRA was diagnosed in a family of Giant Schnauzer
dogs, where three out of seven littermates presented with clinical signs
of PRA around four years of age. The sire and dam were clinically un-
affected and therefore considered likely to be obligate carriers of an
autosomal recessive mutation causing PRA in this family. We sought to
identify the causal mutation of PRA in this Giant Schnauzer family with
the ultimate aim of developing a DNA test, a tool which breeders could
utilise to prevent this form of PRA becoming widespread in the breed.Whole genome sequencing (WGS) of two PRA affected full-siblings
and their unaffected parents was performed. Variants were filtered
based on those segregating appropriately for an autosomal recessive
disorder and those with a predicted pathogenic effect on the coding
sequence and protein. Successive filtering against a total of 568 ge-
nomes (including genomes from the Dog Biomedical Variant Data-
base Consortium and the Animal Health Trust Give a Dog a Genome
bank) reduced an initial set of > 20 million variants down to a single
candidate variant in a novel gene not previously associated with ret-
inal degeneration in any species.
The candidate variant was genotyped in a total of 1,444 dogs of 175
breeds, 10 cross breed dogs and 3 wolves, with our three PRA-affected
Giant Schnauzers being the only homozygotes identified to date. Nine
Giant Schnauzer heterozygotes were identified in addition to heterozy-
gotes in three additional breeds of German origin, including the German
Giant (Gross) and Medium (Mittel) Spitz and Miniature Longhaired Dachs-
hund (MLHD). The genotyping of German Spitz varieties, including 110
Giant Spitz, 21 Medium Spitz, 24 Miniature (Klein) Spitz, 17 Pomeranian
(Zwerg) Spitz, and an additional 27 Giant Schnauzers was carried out by
collaborators at the University of Bern. We screened a total of 163 MLHD
for the candidate variant. Seven German Giant Spitz, one German
Medium Spitz and six MLHD heterozygotes were identified, suggesting
this may be an ancestral, but rare, mutation.
This study highlights the power of using WGS to identify novel genes
associated with disease using a very small number of cases. This
novel candidate gene, harbouring a variant that is predicted to be
the causal mutation of PRA in the Giant Schnauzer, could provide in-
sights into gene discoveries in human retinal degenerations. Further
functional study options are being explored to confirm the candidate
gene’s role in retinal function and maintenance.
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The poster is reviewing Swedish actions to improve health issues re-
lated to Brachycephalic Obstructive Airway Syndrome (BOAS) and
handling the increased attention and awareness of the syndrome.
These actions are
1. forming of working groups composed of various stakeholders,
arranging conferences and production of educational material
for breeders, judges and veterinarians (a,b).
2. reviewing the epidemiology of BOAS in Swedish dogs by
breed club health surveys and insurance data and focusing on
a published report in Swedish (Lagerstedt et. al 2018) on 300
dogs operated at 12 clinics in Sweden during 2014-15-16 (in-
cluding information on breed, gender, age, procedures per-
formed and outcome) Improved diagnostic criteria and follow
ups are proposed.
3. initiating a Nordic inventory on the phenotypic and genotypic
variation in four brachycephalic breeds – English bulldogs,
French bulldogs, Pugs and Boston terriers
Aim
To investigate if there is sufficient phenotypic and genotypic
variation in four brachycephalic breeds to allow selection for a
change in anatomy and thereby reduce the predisposition for
Brachycephalic Obstructive Airway Syndrome (BOAS)
The project is based on “Breed” -gatherings – for dogs of
various background arranged for by the breed clubs and
supported by the four Nordic Kennel Clubs
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Data collection by breed on demography: gender, age, country of
origin, measures: of weight, BodyConditionScore (BCS) and
conformational measurements (i.e. width of Nares (WN),
craniofacial ratio (CFR), neck girth ratio (NGR), photo in
standardised position (whole body and skull)and surveying general
and specific health conditions by a survey to owners and a
veterinary examination (clinical data including BOAS)
Cheek swabs will be collected from each dog for genomic analyses
Analyses of data is intended to compare variation within and between
breeds regarding age, gender, origin and the indicated measures
Out of all dogs described and sampled, 100 individuals of each
breed from each country will be selected for more extensive
studies across-breed quantitative trait locus. By performing
genotyping using the Illumina high density 170K SNP array of
around 400 brachycephalic dogs we will estimate the genomic
variation in each breed.
4. Control measures by a reporting form where deaths and
performed surgical procedures regarding BOAS are registered
as well as an obligatory puppy health certificate to be issued
at time of delivery to a new home.
5. The development of a screening procedure for evaluation of
breathing capacity , thermoregulation and anatomical features
relevant for breathing in adult dogs to initially be used and
registered voluntarily but intended to serve in the future as a
mandatory request for breeding animals.
6. international collaborations on these issues with Nordic Kennel
Clubs and the veterinary organisations (WSAVA / FECAVA) are
described as well as Swedish involvement in the BOAS
activities within International partnership for dogs( IPFD) and
DogWellNet (c,d,e)
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Dog represents a spontaneous model of many genetic diseases in-
cluding cancers and other multifactorial diseases as well asmonogenic diseases. The last 10 years, genetic tools dedicated to
dogs allowed to identify the genetic causes or predisposition to ca-
nine and human homologous genetic conditions. More recently, the
idea emerged that dogs can be of help for therapeutic trials, to
screen and validate new drugs in homologous human cancer types.
To this aim, we created the canine Cani-DNA biobank in 2003 to col-
lect blood and tissue samples from dogs affected with genetic dis-
eases and healthy dogs. Cani-DNA contains the native samples and
extracted nucleic acids as well as clinical and genealogical data, to
distribute samples with high quality controlled procedures. This re-
source is implemented by a French veterinarian network based on
vet practic- es, specialized vet centres and histopathology laborator-
ies. In 2012, a contract signed between Cani-DNA and the 4 French
vet schools and the Antagene Company allowed a national
organization and international visibility. Cani-DNA joined the French
consortium of domesticated animals, CRB-Anim (funded by French
government 2012-2020), aiming to combine genetic and reproduct-
ive resources. To date, Cani-DNA, with its primary site at CNRS
Rennes and secondary sites at the fourth Vet Schools and Antagene
contains almost 20 000 DNA extracted from blood and 3000 nucleic
acids (DNA, RNA) extracted from tissue samples (tumoral and con-
trols), representing 300 breeds and over 100 genetic diseases. Sam-
ples can be sent to implement Cani-DNA and can be distributed for
research purposes, upon e-mail ordering (cani-dna@univ-rennes1.fr)
or through : http://dog-genetics.genouest.org. We plan to facilitate
exchanges and access to such samples for biomedical research with
other European biobanks such as those in Bern with 40 000 samples
from ~100 breeds (T. Leeb) and Helsinki with 60 000 samples from
330 breeds. (H. Lohi).
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The advent of whole genome sequencing (WGS) has promised to
revolutionise genetic research, and the rapid fall in per-sample
costs in recent years has made the revolution an affordable real-
ity for geneticists. The technology is especially useful for the
study of simple Mendelian conditions where disease-causing mu-
tations have the potential to be identified from the WGS of a sin-
gle case. However, when comparing a typical canine genome
with the reference sequence (Can- Fam3.1) or a control genome,
at least 2-3 million variants will typically be identified. Many of
these variants are likely common polymorphisms which could be
excluded by comparing with multiple control genomes. We de-
vised the Give a Dog a Genome (GDG) project to build a re-
source of canine genetic variants across the genome using WGS;
currently projected to contain 90 genomes from 78 breeds, and
investigate genetic diseases in at least 69 breeds. We used a
crowd-funding approach, with the costs of the project being
shared between multiple stakeholders. To date (two years after
GDG was launched), 74 samples from 69 breeds have been se-
quenced comprising 62 dogs affected with a suspected genetic
condition (27 conditions in total) and 12 apparently healthy older
dogs. The GDG variant bank has been used to validate several
disease-associated mutations and DNA tests have been developed
to improve the health and wellbeing of dogs. All of the WGS
data generated through GDG will be shared with the Dog Bio-
medical Variant Database Consortium (DBVDC), and specific se-
quences will be shared with at least 20 scientists from Europe
and the USA to contribute to their research.
Keywords: Canine, Genomics and Variation, Inherited Disease
Canine Genetics and Epidemiology 2018, 5(Suppl 2):7 Page 7 of 8P4
Population structure of Leonberger dogs
Anna Letko1, Katie Minor2, Jim Mickelson2, Franz Seefried3,
Cord Drögemüller1
1Institute of Genetics, University of Bern, Switzerland; 2Department of
Veterinary and Biomedical Sciences, University of Minnesota,
Minneapolis, USA; 3Qualitas AG, Zug, Switzerland
Correspondence: Anna Letko
Canine Genetics and Epidemiology 2018, 5(Suppl 2):P4
The Leonberger is a giant dog breed formed in the 1850s in Germany. This
breed appears to have higher predisposition to neurodegenerative disor-
ders and osteosarcoma than other breeds. Every second polyneuropathy-
diagnosed Leonberger can be explained by dominantly inherited
ARHGEF10 or GJA9 variants and a recently described recessive NAPEPLD
variant identifies a juvenile-onset leukoencephalomyelopathy. Breeders
also report shorter lifespan and lower fertility in Leonberger dogs. These
problems, combined, imply inbreeding depression. We assessed the gen-
etic diversity of the Leonberger population from extensive pedigree data
(including more than 145,000 animals) as well as single nucleotide poly-
morphism (SNP) genotypes based on 170K array data of 1,175 dogs.
Pedigree analysis was done using open source software EVA v3.0. The
completeness index over 5 generations of available pedigrees was
above 99% for animals from the latest cohorts and exceeded 80% in
1935. We identified 22 founder animals in the population and a severe
bottleneck during the 1940s with only 17 inbred dogs registered in
1946. Since the year 2000 approximately 4,400 dogs are born every
year worldwide. The average litter size across cohorts was 6.5 puppies
and a constant generation interval of 4 years was observed. The aver-
age inbreeding coefficient F was estimated to be 0.29 with a maxF of
0.60. The popular sire effect is apparent since a quarter of all sires pro-
duces two thirds of all offspring and the three top males sired more
than 330 registered animals each. Additionally, SNP array data of 1,175
individuals sampled worldwide were investigated. These animals repre-
sent the current population of Leonberger well and therefore subpopu-
lations were expected due to large geographic distances between
breeders. However, multidimensional scaling (MDS) of pairwise genetic
distances was carried out and revealed no significant clustering. Add-
itionally, a high level of homozygosity was observed.
Despite increasing population size observed in last cohorts, considerable gen-
etic diversity has been lost due to the bottleneck in the last century. The use
of popular sires and high level of inbreeding may have facilitated undesirable
genetic traits to spread rapidly within the gene pool of the Leonberger popu-
lation. Maintaining the genetic diversity is possible through informed selec-
tion decisions (especially to include more animals in breeding practice, avoid
the use of popular sires and aim to minimize inbreeding) which would con-
tribute to reduce the incidence of health problems. Crossbreeding with sev-
eral candidate breeds could help optimize long-term genetic diversity.
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Canine Genetics and Epidemiology 2018, 5(Suppl 2):P5Recent efforts have extended the dog genome annotation with the
discovery of thousands of long non coding RNAs (lncRNAs) using the
machine-learning based tool FEELnc [1]. Although lncRNAs have
been shown to play important roles in many biological processes,
and particularly in cancers [2], it remains challenging to assign func-
tions and classify lncRNAs in order to interpret their impact on can-
cers and genetic diseases. Here, we integrated genomic and
transcriptomic features from the extended canFam3.1-plus annota-
tion to perform bioinformatic functional predictions of lncRNAs. We
first characterized expression patterns of 10,444 canine lncRNAs in 26
distinct tissues representing various histological and anatomical local-
izations. We defined tissue specificity profiles of lncRNAs and de-
duced potential functionality and evolutionary origins through
comparative genomic and transcriptomic analysis with human data
from the ENCODE project (ENCyclopedia Of DNA Elements).
As in human, we show that canine lncRNAs are lower expressed than
protein coding genes (mRNAs). Among the 26 tissues, we detected
4,600 tissue-specific lncRNAs. Unsupervised hierarchical clustering
based on lncRNA expression levels recapitulates tissue origins and
pinpoint candidate lncRNAs likely associated with specialized func-
tions, such as nervous and integumentary clusters. Furthermore, we
identified more than 900 conserved dog-human lncRNAs for which
we show their overall reproducible expression patterns in both spe-
cies through comparative transcriptomics. We then constructed co-
expression networks and found significant correlations (| rho | > 0.5
and adjusted p-value (BH) < 0.05) for 7,615 lincRNA:mRNA and 524
antisense:mRNA pairs. These results revealed co-expressed modules
that may predict regulatory relationships and/or the evolutionary ori-
gin of subsets of lncRNAs. Using functional annotations based on GO
biological processes terms, we found 23 clusters significantly
enriched (adjusted p-value (BH) < 0.05) corresponding to develop-
mental processes ‘sensory organ development’, ‘axon development’
or ‘hindbrain development’.
We conducted a pilot study of melanoma in dogs, we performed dif-
ferential expression analysis using matched tumour/control RNA-seq
samples from canine buccal melanomas. We identified 930 lncRNAs
with significant differential expression between tumour and control
samples (FDR < 0.01). These lncRNAs represent potential biomarkers
and/or candidate to study tumorigenesis of melanomas in dogs.
Moreover, more than 100 of the 930 lncRNAs are conserved in hu-
man and can be used for further evaluating their therapeutic poten-
tial in both human and veterinary medicine. Altogether, this genomic
and transcriptomic integrative study of lncRNAs constitutes a major
resource for biomedical research in the dog species.
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Even with careful study design and extensive validation, large data-
sets are often heterogeneous and require cleaning prior to analysis
to prevent losses in research validity, quality and statistical power.
Many publications report that data was ‘cleaned’ but few studies
Canine Genetics and Epidemiology 2018, 5(Suppl 2):7 Page 8 of 8document the process reproducibly and values identified as ‘outliers’
are commonly deleted without reporting the possible causes of error.
Our aim was to develop a novel, automated data cleaning algorithm
for growth (height and weight) that could be applied to large
datasets.
Dogslife is an internet-based, longitudinal cohort study of Kennel
Club registered Labrador Retrievers living in the UK, which was
launched in 2010 and has over 7500 registered dogs to date. The
main objective of Dogslife is to identify risk factors for canine health
and disease by collecting information from owners via regular ques-
tionnaires. In addition to questionnaire data, the study has collected
DNA and faecal samples from subsets of the cohort, which has pro-
duced genomic and microbiome data.
We developed our data cleaning pipeline in R software and used
rule-based approaches, non-linear mixed-effects mathematical
models and text analysis to identify common errors such as duplicate
entries, typing, decimal point, unit, menu/option, intentional,
website-generated and measurement errors. Individuals were permit-
ted to differ from the population by making use of repeated mea-
surements and alternative data sources. The method avoids the
modification of unusual but biologically plausible values, prioritise
data repair over removal and explicitly report the decision making
process behind why a particular data entry is modified or deleted.
We validated our cleaning algorithm for growth variables (weight
and height) on three other independent data sources from studies
with fundamentally different designs; veterinary consultationLabrador Retriever weight records from the SAVSNET (Small Animal
Veterinary Surveillance Network), clinical Labrador Retriever weight
records from a veterinary hospital network and a publically available
(via the UK Data Service) human weight and height data from
CLOSER (Cohort & Longitudinal Studies Enhancement Resources)
with varying proportions of artificially simulated errors. We found
that our algorithm could be reproducibly applied as an effective data
cleaning method on all of the validation datasets. We also compared
our method to uncleaned data and six different cleaning methods
and found that our algorithm out-performed these with greater ac-
curacy and fewer unnecessary data deletions.
There is an increasing demand for data cleaning methodologies to
be thoroughly reported so that they can be reproduced, tested and
adapted by the wider research community. In the future, it is vital
that data cleaning is considered an integral part of study design and
should be considered as early as possible in order to ensure that the
quality of the data is conserved. Our methods have broad applicabil-
ity to longitudinal and cross-sectional growth data and we propose
that they could be adapted for use in other breeds, species and
fields.
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